Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Withanolide B

😃Good
Catalog No. TN2310Cas No. 56973-41-2

Withanolide B, a natural product isolated from Withania somnifera Dunal, promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) via the ERK1/2 and Wnt/β-catenin signalling pathways, thereby enhancing bone healing. Withanolide B exhibits affinity for the catalytic domain of PARP-1.

Withanolide B

Withanolide B

😃Good
Catalog No. TN2310Cas No. 56973-41-2
Withanolide B, a natural product isolated from Withania somnifera Dunal, promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) via the ERK1/2 and Wnt/β-catenin signalling pathways, thereby enhancing bone healing. Withanolide B exhibits affinity for the catalytic domain of PARP-1.
Pack SizePriceAvailabilityQuantity
1 mg$3326-8 weeks
5 mg$9326-8 weeks
10 mgInquiry6-8 weeks
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Batch Information

Select Batch
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Withanolide B, a natural product isolated from Withania somnifera Dunal, promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs) via the ERK1/2 and Wnt/β-catenin signalling pathways, thereby enhancing bone healing. Withanolide B exhibits affinity for the catalytic domain of PARP-1.
Targets&IC50
SK-N-SH cells:14.84±1.45 μM
In vitro
Methods: SK-N-SH cells were treated with Withanolide B (10-100 μM, 48 hours), and cell viability was assessed using the MTT assay.
Results: The IC50 value of Withanolide B for SK-N-SH cells was 14.84±1.45 μM, indicating that Withanolide B exhibits low toxicity to neuronal cells. [1]
In vivo
Methods: By injecting Withanolide B (10 mg/kg) into the bone defect site of the SD rat tibial osteotomy model, the effect of Withanolide B on the osteogenic differentiation of hBMSCs was investigated. Results: Micro-CT scanning and histological analysis demonstrated that Withanolide B significantly promoted the healing of bone defects. [2]
Chemical Properties
Molecular Weight454.6
FormulaC28H38O5
Cas No.56973-41-2
Smiles[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H]4O[C@@H]4[C@@]4(O)CC=CC(=O)[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)[C@@]1([H])CC(C)=C(C)C(=O)O1
Relative Density.1.31g/cm3
ColorWhite
AppearanceSolid
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Acetone: 0.8 mg/mL (1.76 mM), Sonication is recommended.
DMSO: 2.5 mg/mL (5.5 mM), Sonication is recommended.
Solution Preparation Table
Acetone/DMSO
1mg5mg10mg50mg
1 mM2.1997 mL10.9987 mL21.9974 mL109.9868 mL
DMSO
1mg5mg10mg50mg
5 mM0.4399 mL2.1997 mL4.3995 mL21.9974 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Withanolide B | purchase Withanolide B | Withanolide B cost | order Withanolide B | Withanolide B chemical structure | Withanolide B in vivo | Withanolide B in vitro | Withanolide B formula | Withanolide B molecular weight